KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder for investors with losses over $100,000 in Kyverna Therapeutics, Inc. to file lead plaintiff applications by February 7, 2025, in a class action lawsuit related to the company's IPO.
January 14, 2025 | 1:15 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its IPO, with a lead plaintiff deadline set for February 7, 2025. This legal action could impact the company's stock price.
The class action lawsuit against Kyverna Therapeutics is directly related to its IPO, which could lead to negative sentiment and potential stock price decline. The legal proceedings may cause uncertainty among investors, impacting the stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100